Phlebitis Experiences of Intensive Care Nurses

March 18, 2026 updated by: Kutahya Health Sciences University

Phlebitis Experiences of Intensive Care Nurses: A Qualitative Study

It is important to reveal the phlebitis experiences of nurses. The data obtained from the phlebitis experiences of nurses are important in terms of preventing phlebitis and supporting patient safety practices. In the studies conducted to date, no study has been found in the literature that qualitatively examines the phlebitis experiences of intensive care nurses. This study is the first to be conducted in this respect, which constitutes the originality of the research. It is expected to guide clinician and academic nurses in phlebitis assessment and phlebitis care planning and to contribute to the literature.

Study Overview

Study Type

Observational

Enrollment (Actual)

20

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Kütahya
      • Kütahya, Kütahya, Turkey (Türkiye), 43000
        • Kutahya Health Sciences University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Intensive Care nurses

Description

Inclusion Criteria:

  • Voluntarily accepting to participate in the study
  • Being the primary nurse of a patient who developed phlebitis,
  • Having at least 1 year of work experience.

Exclusion Criteria:

  • Being assigned to the unit for a short period of time
  • Being on leave or sick leave,
  • Not accepting to participate in the study,
  • Leaving the study during the data collection process.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Themes Identified in ICU Nurses' Experiences with Phlebitis Management
Time Frame: Within the first 2 months following the initiation of the study
Identification of distinct thematic categories from ICU nurses' experiences concerning the recognition, prevention, care practices, and clinical challenges related to phlebitis. Each theme will be extracted through thematic analysis of qualitative data obtained from semi-structured interviews. Method of Analysis: Braun & Clarke's Thematic Analysis Method Unit of Measure: Number of distinct themes identified
Within the first 2 months following the initiation of the study
Perceived Barriers and Facilitators in Phlebitis Management
Time Frame: Within 2 month after the completion of data collection
Evaluation and classification of ICU nurses' perceptions regarding institutional, educational, and individual-level factors affecting phlebitis assessment and management. Each perceived barrier or facilitator will be categorized based on content analysis of semi-structured interview transcripts. Method of Analysis: Content Analysis Methodology Unit of Measure: Number of identified barriers and facilitators.
Within 2 month after the completion of data collection

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 15, 2025

Primary Completion (Actual)

August 15, 2025

Study Completion (Actual)

March 15, 2026

Study Registration Dates

First Submitted

June 12, 2025

First Submitted That Met QC Criteria

July 2, 2025

First Posted (Actual)

July 4, 2025

Study Record Updates

Last Update Posted (Actual)

March 20, 2026

Last Update Submitted That Met QC Criteria

March 18, 2026

Last Verified

June 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • KHSU20250607

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Phlebitis

Clinical Trials on It is a qualitative type of study that will be conducted through face-to-face interviews.

Subscribe